Channel Avatar

Simulations Plus, Inc. @UCT4wMdIEnI95nlyLfRJY7Ww@youtube.com

2.4K subscribers - no pronouns :c

Simulations Plus, Inc., is a premier developer of drug disco


01:56:17
Leveraging PBPK/PBBM in Support of BCS Class 3 Biowaivers
06:39
It's That Easy! 10 Minute Answers to Your Drug Discovery Needs
01:02:30
AI for Pharmacological Modeling
01:02:34
The Application of Artificial Intelligence/Machine Learning in Drug Development and Regulation
01:34
Evolve PK+ an AI-driven drug design platform that incorporates GastroPlus® PBPK predictions
01:34
DILIsym X: Quantitative Systems Toxicology Software for Predicting Drug-Induced Liver Injury
57:08
ADMET Predictor® 12 Webinar
01:36
ADMET Predictor® 12: Predict with Confidence
59:02
Visionary Voices: Weathering the Change of Clinical Trials
01:40
Adaptive Learning with Pro-ficiency
01:09
Patient Education for Clinical Research
01:37
Get to know the Pro-ficiency Platform
02:05
A Smarter Approach to Meetings
01:57
Immersive Learning Capabilities for the Life Sciences Industry
01:13
Protocol Optimization Solution
02:59
Pro-ficiency - A Simulations Plus Company
37:40
Treating Systemic Lupus Erythematosus: How QSP Can Support Drug Development & Clinical Trial Design
18:08
GPX™ Tutorial Series: Compound Forms and Solubility
27:00
GPX™ Tutorial Series: Recreating a GastroPlus X Project in Legacy GastroPlus
21:39
GPX™ Tutorial Series: In Vitro In Vivo Correlation (IVIVC) in GastroPlus X
24:25
GPX™ Tutorial Series: PBPK Module in GastroPlus X
05:06
GPX™ Tutorial Series: Lab Book in GastroPlus X
13:45
GPX™ Tutorial Series: Reporting Outputs in GastroPlus X
09:52
GPX™ Tutorial Series: Simplified Absorption and Pharmacokinetics
11:15
GPX™ Tutorial Series: Advanced compartmental and transit (ACAT) in GastroPlus X
07:32
GPX™ Tutorial Series: How to Import and Export Assets
11:21
GPX™ Tutorial Series: PDPlus™ in GastroPlus X
17:26
GPX™ Tutorial Series: PKPlus™ in GastroPlus X
00:55
Consult & Coach - Accelerate your program and invest in your future
01:06
Discover the next level in PBPK modeling with GPX™
09:47
How to use the Verification Suite in GPX™
53:16
Demystifying GPX™ Installation Expert Insights and Practical Tips
10:00
How to Locate & Install GPX™
02:25
GPX™ - Built on 25+ Years of Research and Model Validation
55:51
GPX™ The Next Level PBPK Platform
03:36
GPX™ Tutorial Series: The GPX™ Paradigm
15:27
GPX™ Tutorial Series: Legacy Import
18:40
GPX™ Tutorial Series: Creating a Project from Scratch in GPX
09:32
GPX™ Tutorial Series: Dosing Schedules
11:44
GPX™ Tutorial Series: Physiologies and Physiology Schedules in GPX
10:14
GPX™ Tutorial Series: ADMET Predictor Import for GPX
17:44
GPX™ Tutorial Series: GastroPlus X Run Modes Population Simulation & Virtual Bioequivalence
11:13
GPX™ Tutorial Series: GastroPlus X Run Modes Simulation & Optimization
11:45
GPX™ Tutorial Series: GastroPlus X Run Modes Parameter Sensitivity Analysis (PSA)
18:00
GPX™ Tutorial Series: Metabolism and Transporter Module
15:55
GPX™ Tutorial Series: Drug-Drug Interaction (DDI) Module in GastroPlus X
01:38
GastroPlus X Next Level PBPK Modeling
01:00:36
QSP and Oncology: How QSP Modeling Can Accelerate Therapy Development for Solid Tumors
01:50:47
DDIs: How to Use Your Predictions to Support Regulatory Submission
03:25
What is the importance of model-informed drug (MIDD) development?
01:18
OBESITYsym Lose the Nausea in Your Weight Loss Therapies
02:03:26
International Perspectives on Model-Informed Precision Dosing: From the Data to the Patients
58:18
Unlocking the Power of PBPK Modeling: PBPK for First-in-Human and Beyond
59:15
Weight Loss Without Nausea: How QSP Modeling Can Optimize Obesity Treatments
03:00
Why does it matter if you're able to predict nausea or other side effects?
01:53
Why do pKa predictions matter?
06:54
It's That Easy! 10 Minute Answers to Your Drug Discovery Challenges - Episode 2
58:42
Using QST Predictions to Optimize Your Drug, De-Risk Your Regulatory Submission, and Guide R&D
13:49
It's That Easy! 10 Minute Answers to Your Drug Discovery Challenges
01:59:11
SLP Investor Day 2023